Hemostatic Agents Market Report

Global and Region Hemostatic Agents Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：139
  • REPORT CODE：GMM968749
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Hemostatic Agents market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Hemostatic Agentsmarket, defines the market attractiveness level of Hemostatic Agents market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Hemostatic Agents industry, describes the types of Hemostatic Agents market, the applications of major players and the market size, and deeply analyzes the current situation of the global Hemostatic Agents market and the development prospects and opportunities of Hemostatic Agents industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Hemostatic Agents market in Chapter 13.

    By Player:

    • Baxter International

    • CryoLife

    • Z-Medica

    • Advanced Medical Solutions

    • BioCer Entwicklungs

    • Vascular Solutions

    • C R Bard

    • B Braun Melsungen

    • Gelita Medical

    • Equimedical

    • The Medicines Company

    • Biom’Up SAS

    • Integra LifeSciences

    • Marine Polymer Technologies

    • Pfizer

    • Ethicon

    • Anika Therapeutics

    By Type:

    • Gelation Sponge

    • Oxidized Regenerated Cellulose Based Hemostats

    • Others

    By End-User:

    • Hospitals

    • Surgical Centers

    • Nursing Homes

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Hemostatic Agents Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Hemostatic Agents Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Hemostatic Agents Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Hemostatic Agents Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Hemostatic Agents Market Analysis and Outlook to 2022

    • 7.1 Global Hemostatic Agents Consumption (2017-2022)

    • 7.2 United States Hemostatic Agents Consumption (2017-2022)

    • 7.3 Europe Hemostatic Agents Consumption (2017-2022)

    • 7.4 China Hemostatic Agents Consumption (2017-2022)

    • 7.5 Japan Hemostatic Agents Consumption (2017-2022)

    • 7.6 India Hemostatic Agents Consumption (2017-2022)

    • 7.7 South Korea Hemostatic Agents Consumption (2017-2022)

    8 Region and Country-wise Hemostatic Agents Market Analysis and Outlook to 2028

    • 8.1 Global Hemostatic Agents Consumption Forecast (2022-2028)

    • 8.2 United States Hemostatic Agents Consumption Forecast (2022-2028)

    • 8.3 Europe Hemostatic Agents Consumption Forecast (2022-2028)

    • 8.4 China Hemostatic Agents Consumption Forecast (2022-2028)

    • 8.5 Japan Hemostatic Agents Consumption Forecast (2022-2028)

    • 8.6 India Hemostatic Agents Consumption Forecast (2022-2028)

    • 8.7 South Korea Hemostatic Agents Consumption Forecast (2022-2028)

    9 Global Hemostatic Agents Market Outlook by Types and Applications to 2022

    • 9.1 Global Hemostatic Agents Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Gelation Sponge Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Oxidized Regenerated Cellulose Based Hemostats Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Hemostatic Agents Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Surgical Centers Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Nursing Homes Consumption and Growth Rate (2017-2022)

    10 Global Hemostatic Agents Market Outlook by Types and Applications to 2028

    • 10.1 Global Hemostatic Agents Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Gelation Sponge Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Oxidized Regenerated Cellulose Based Hemostats Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Hemostatic Agents Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Nursing Homes Consumption Forecast and Growth Rate (2022-2028)

    11 Global Hemostatic Agents Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Hemostatic Agents Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Hemostatic Agents Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Hemostatic Agents Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Hemostatic Agents Market Competitive Analysis

    • 14.1 Baxter International

      • 14.1.1 Baxter International Company Details

      • 14.1.2 Baxter International Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Baxter International Hemostatic Agents Product and Service

    • 14.2 CryoLife

      • 14.2.1 CryoLife Company Details

      • 14.2.2 CryoLife Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 CryoLife Hemostatic Agents Product and Service

    • 14.3 Z-Medica

      • 14.3.1 Z-Medica Company Details

      • 14.3.2 Z-Medica Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Z-Medica Hemostatic Agents Product and Service

    • 14.4 Advanced Medical Solutions

      • 14.4.1 Advanced Medical Solutions Company Details

      • 14.4.2 Advanced Medical Solutions Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Advanced Medical Solutions Hemostatic Agents Product and Service

    • 14.5 BioCer Entwicklungs

      • 14.5.1 BioCer Entwicklungs Company Details

      • 14.5.2 BioCer Entwicklungs Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 BioCer Entwicklungs Hemostatic Agents Product and Service

    • 14.6 Vascular Solutions

      • 14.6.1 Vascular Solutions Company Details

      • 14.6.2 Vascular Solutions Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Vascular Solutions Hemostatic Agents Product and Service

    • 14.7 C R Bard

      • 14.7.1 C R Bard Company Details

      • 14.7.2 C R Bard Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 C R Bard Hemostatic Agents Product and Service

    • 14.8 B Braun Melsungen

      • 14.8.1 B Braun Melsungen Company Details

      • 14.8.2 B Braun Melsungen Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 B Braun Melsungen Hemostatic Agents Product and Service

    • 14.9 Gelita Medical

      • 14.9.1 Gelita Medical Company Details

      • 14.9.2 Gelita Medical Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Gelita Medical Hemostatic Agents Product and Service

    • 14.10 Equimedical

      • 14.10.1 Equimedical Company Details

      • 14.10.2 Equimedical Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Equimedical Hemostatic Agents Product and Service

    • 14.11 The Medicines Company

      • 14.11.1 The Medicines Company Company Details

      • 14.11.2 The Medicines Company Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 The Medicines Company Hemostatic Agents Product and Service

    • 14.12 Biom’Up SAS

      • 14.12.1 Biom’Up SAS Company Details

      • 14.12.2 Biom’Up SAS Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Biom’Up SAS Hemostatic Agents Product and Service

    • 14.13 Integra LifeSciences

      • 14.13.1 Integra LifeSciences Company Details

      • 14.13.2 Integra LifeSciences Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Integra LifeSciences Hemostatic Agents Product and Service

    • 14.14 Marine Polymer Technologies

      • 14.14.1 Marine Polymer Technologies Company Details

      • 14.14.2 Marine Polymer Technologies Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Marine Polymer Technologies Hemostatic Agents Product and Service

    • 14.15 Pfizer

      • 14.15.1 Pfizer Company Details

      • 14.15.2 Pfizer Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Pfizer Hemostatic Agents Product and Service

    • 14.16 Ethicon

      • 14.16.1 Ethicon Company Details

      • 14.16.2 Ethicon Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Ethicon Hemostatic Agents Product and Service

    • 14.17 Anika Therapeutics

      • 14.17.1 Anika Therapeutics Company Details

      • 14.17.2 Anika Therapeutics Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Anika Therapeutics Hemostatic Agents Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Hemostatic Agents

    • Figure Hemostatic Agents Picture

    • Table Global Hemostatic Agents Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Hemostatic Agents Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Hemostatic Agents Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Hemostatic Agents Consumption by Country (2017-2022)

    • Figure United States Hemostatic Agents Consumption and Growth Rate (2017-2022)

    • Table Europe Hemostatic Agents Consumption and Growth Rate (2017-2022)

    • Figure China Hemostatic Agents Consumption and Growth Rate (2017-2022)

    • Figure Japan Hemostatic Agents Consumption and Growth Rate (2017-2022)

    • Figure India Hemostatic Agents Consumption and Growth Rate (2017-2022)

    • Figure South Korea Hemostatic Agents Consumption and Growth Rate (2017-2022)

    • Figure Global Hemostatic Agents Consumption Forecast by Country (2022-2028)

    • Figure United States Hemostatic Agents Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Hemostatic Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Hemostatic Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Hemostatic Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Hemostatic Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Hemostatic Agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gelation Sponge Consumption and Growth Rate (2017-2022)

    • Figure Global Oxidized Regenerated Cellulose Based Hemostats Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Surgical Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Nursing Homes Consumption and Growth Rate (2017-2022)

    • Figure Global Gelation Sponge Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oxidized Regenerated Cellulose Based Hemostats Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Nursing Homes Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Hemostatic Agents Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Hemostatic Agents Export by Region (Top 5 Countries) (2017-2028)

    • Table Baxter International (Foundation Year, Company Profile and etc.)

    • Table Baxter International Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)

    • Table Baxter International Hemostatic Agents Product and Service

    • Table CryoLife (Foundation Year, Company Profile and etc.)

    • Table CryoLife Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)

    • Table CryoLife Hemostatic Agents Product and Service

    • Table Z-Medica (Foundation Year, Company Profile and etc.)

    • Table Z-Medica Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)

    • Table Z-Medica Hemostatic Agents Product and Service

    • Table Advanced Medical Solutions (Foundation Year, Company Profile and etc.)

    • Table Advanced Medical Solutions Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)

    • Table Advanced Medical Solutions Hemostatic Agents Product and Service

    • Table BioCer Entwicklungs (Foundation Year, Company Profile and etc.)

    • Table BioCer Entwicklungs Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioCer Entwicklungs Hemostatic Agents Product and Service

    • Table Vascular Solutions (Foundation Year, Company Profile and etc.)

    • Table Vascular Solutions Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)

    • Table Vascular Solutions Hemostatic Agents Product and Service

    • Table C R Bard (Foundation Year, Company Profile and etc.)

    • Table C R Bard Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)

    • Table C R Bard Hemostatic Agents Product and Service

    • Table B Braun Melsungen (Foundation Year, Company Profile and etc.)

    • Table B Braun Melsungen Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)

    • Table B Braun Melsungen Hemostatic Agents Product and Service

    • Table Gelita Medical (Foundation Year, Company Profile and etc.)

    • Table Gelita Medical Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gelita Medical Hemostatic Agents Product and Service

    • Table Equimedical (Foundation Year, Company Profile and etc.)

    • Table Equimedical Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)

    • Table Equimedical Hemostatic Agents Product and Service

    • Table The Medicines Company (Foundation Year, Company Profile and etc.)

    • Table The Medicines Company Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)

    • Table The Medicines Company Hemostatic Agents Product and Service

    • Table Biom’Up SAS (Foundation Year, Company Profile and etc.)

    • Table Biom’Up SAS Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biom’Up SAS Hemostatic Agents Product and Service

    • Table Integra LifeSciences (Foundation Year, Company Profile and etc.)

    • Table Integra LifeSciences Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)

    • Table Integra LifeSciences Hemostatic Agents Product and Service

    • Table Marine Polymer Technologies (Foundation Year, Company Profile and etc.)

    • Table Marine Polymer Technologies Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)

    • Table Marine Polymer Technologies Hemostatic Agents Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Hemostatic Agents Product and Service

    • Table Ethicon (Foundation Year, Company Profile and etc.)

    • Table Ethicon Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ethicon Hemostatic Agents Product and Service

    • Table Anika Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Anika Therapeutics Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)

    • Table Anika Therapeutics Hemostatic Agents Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US